PMID- 36950101 OWN - NLM STAT- MEDLINE DCOM- 20230324 LR - 20230329 IS - 2296-2565 (Electronic) IS - 2296-2565 (Linking) VI - 11 DP - 2023 TI - Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018. PG - 1133194 LID - 10.3389/fpubh.2023.1133194 [doi] LID - 1133194 AB - OBJECTIVE: The hepatotoxicity of exposure to a single heavy metal has been examined in previous studies. However, there is limited evidence on the association between heavy metals mixture and non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver disease (MAFLD). This study aims to investigate the associations of 13 urinary metals, individually and jointly, with NAFLD, MAFLD, and MAFLD components. METHODS: This study included 5,548 adults from the National Health and Nutrition Examination Survey (NHANES) 2003-2018. Binary logistic regression was used to explore the associations between individual metal exposures and MAFLD, NAFLD, and MAFLD components. Bayesian kernel machine regression (BKMR) and Quantile-based g-computation (QGC) were used to investigate the association of metal mixture exposure with these outcomes. RESULTS: In single metal analysis, increased levels of arsenic [OR 1.09 (95%CI 1.03-1.16)], dimethylarsinic acid [1.17 (95%CI 1.07-1.27)], barium [1.22 (95%CI 1.14-1.30)], cobalt [1.22 (95%CI 1.11-1.34)], cesium [1.35 (95%CI 1.18-1.54)], molybdenum [1.45 (95%CI 1.30-1.62)], antimony [1.18 (95%CI 1.08-1.29)], thallium [1.49 (95%CI 1.33-1.67)], and tungsten [1.23 (95%CI 1.15-1.32)] were significantly associated with MAFLD risk after adjusting for potential covariates. The results for NAFLD were similar to those for MAFLD, except for arsenic, which was insignificantly associated with NAFLD. In mixture analysis, the overall metal mixture was positively associated with MAFLD, NAFLD, and MAFLD components, including obesity/overweight, diabetes, and metabolic dysfunction. In both BKMR and QGC models, thallium, molybdenum, tungsten, and barium mainly contributed to the positive association with MAFLD. CONCLUSION: Our study indicated that exposure to heavy metals, individually or cumulatively, was positively associated with NAFLD, MAFLD, and MAFLD components, including obesity/overweight, diabetes, and metabolic dysfunction. Additional research is needed to validate these findings in longitudinal settings. CI - Copyright (c) 2023 Xie, Aimuzi, Si, Qu and Jiang. FAU - Xie, Zhilan AU - Xie Z AD - School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. FAU - Aimuzi, Ruxianguli AU - Aimuzi R AD - School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. FAU - Si, Mingyu AU - Si M AD - School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. FAU - Qu, Yimin AU - Qu Y AD - School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. FAU - Jiang, Yu AU - Jiang Y AD - School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230306 PL - Switzerland TA - Front Public Health JT - Frontiers in public health JID - 101616579 RN - 81AH48963U (Molybdenum) RN - AD84R52XLF (Thallium) RN - 24GP945V5T (Barium) RN - N712M78A8G (Arsenic) RN - V9306CXO6G (Tungsten) SB - IM MH - Adult MH - Humans MH - *Non-alcoholic Fatty Liver Disease/epidemiology MH - Molybdenum MH - Nutrition Surveys MH - Thallium MH - Barium MH - *Arsenic MH - Bayes Theorem MH - Overweight MH - Tungsten MH - Obesity PMC - PMC10025549 OTO - NOTNLM OT - Bayesian kernel machine regression OT - heavy metals OT - metabolic associated fatty liver disease OT - non-alcoholic fatty liver disease OT - quantile-based g-computation COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/03/24 06:00 MHDA- 2023/03/25 06:00 PMCR- 2023/03/06 CRDT- 2023/03/23 02:20 PHST- 2022/12/28 00:00 [received] PHST- 2023/02/14 00:00 [accepted] PHST- 2023/03/23 02:20 [entrez] PHST- 2023/03/24 06:00 [pubmed] PHST- 2023/03/25 06:00 [medline] PHST- 2023/03/06 00:00 [pmc-release] AID - 10.3389/fpubh.2023.1133194 [doi] PST - epublish SO - Front Public Health. 2023 Mar 6;11:1133194. doi: 10.3389/fpubh.2023.1133194. eCollection 2023.